Skip to main content
Biocure Technology Inc. logo

Biocure Technology Inc. — Investor Relations & Filings

Ticker · CURE.X LEI · 529900KSL59IBBDYBU95 CSE Manufacturing
Filings indexed 149 across all filing types
Latest filing 2023-05-30 Regulatory Filings
Country CA Canada
Listing CSE CURE.X

About Biocure Technology Inc.

https://biocuretech.com/

Biocure Technology Inc. is a biopharmaceutical company specializing in the development and commercialization of advanced biological medicines. The company's core focus areas include proprietary CAR T-cell therapies designed to treat various cancers, such as leukemia, lung, and breast cancer. Concurrently, Biocure is engaged in the development and commercialization of major biosimilar pharmaceutical products, aiming to improve the accessibility of complex biological treatments. Furthermore, the company pursues novel, highly-efficacious therapies for severe diseases caused by RNA viruses where significant unmet medical needs exist.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Regulatory Filings
2023-05-30 English
News release - English.pdf
Regulatory Filings
2023-05-17 English
News release - English.pdf
Regulatory Filings
2023-02-21 English
News release - English.pdf
Regulatory Filings
2023-02-08 English
News release - English.pdf
Regulatory Filings
2023-02-08 English
Material document(s).pdf
Regulatory Filings
2023-02-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.